p-coumaric acid |
4-Hydroxycinnamic acid |
501-98-4 |
p-Hydroxycinnamic acid |
trans-4-Hydroxycinnamic acid |
7400-08-0 |
4-Coumaric acid |
trans-p-Coumaric acid |
p-Cumaric acid |
3-(4-hydroxyphenyl)acrylic acid |
p-Hydroxy-cinnamic acid |
Para-Coumaric acid |
Naringeninic acid |
Hydroxycinnamic acid |
(E)-p-Coumaric acid |
trans-4-coumaric acid |
trans-p-Coumarinic acid |
(E)-3-(4-Hydroxyphenyl)acrylic acid |
Cinnamic acid, p-hydroxy- |
(E)-p-Hydroxycinnamic acid |
2-propenoic acid, 3-(4-hydroxyphenyl)-, (2E)- |
4'-hydroxycinnamic acid |
trans-p-Hydroxycinnamic acid |
p-Hydroxyphenylacrylic acid |
(2E)-3-(4-hydroxyphenyl)prop-2-enoic acid |
3-(4-Hydroxyphenyl)-2-propenoic acid |
4-coumarate |
Cinnamic acid, p-hydroxy-, (E)- |
trans-p-Hydroxycinnamate |
2-Propenoic acid, 3-(4-hydroxyphenyl)- |
(E)-3-(4-Hydroxyphenyl)-2-propenoic acid |
(E)-3-(4-hydroxyphenyl)prop-2-enoic acid |
4-Hydroxycinnamate |
(2E)-3-(4-hydroxyphenyl)acrylic acid |
beta-(4-Hydroxyphenyl)acrylic acid |
NSC 59260 |
trans-4-hydroxycinnamate |
UNII-IBS9D1EU3J |
IBS9D1EU3J |
EINECS 231-000-0 |
Para coumaric acid |
(E)-4-hydroxycinnamic acid |
3-(4-hydroxyphenyl)prop-2-enoic acid |
NSC 674321 |
p-coumarate |
2-Propenoic acid, 3-(4-hydroxyphenyl)-, (E)- |
BRN 2207381 |
BRN 2207383 |
CHEBI:32374 |
ORISTAR PCA |
parahydroxycinnamic acid |
MFCD00004399 |
NSC-59260 |
NSC-674321 |
4-hydroxy cinnamic acid |
CHEMBL66879 |
PARA HYDROXYCINNAMIC ACID |
beta-[4-Hydroxyphenyl]acrylic acid |
0-10-00-00297 (Beilstein Handbook Reference) |
4-10-00-01005 (Beilstein Handbook Reference) |
NSC674321 |
trans-p-coumarate |
Dehydroepiandrosterone-[D6] (CertiMass solution) |
3-(4-hydroxyphenyl)acrylate |
.beta.-[4-Hydroxyphenyl]acrylic acid |
trans-HPPA |
(E)-3-[4-hydroxyphenyl]-2-propenoic acid |
4-coumaric acid, (E)-isomer |
4-Hydroxycinnamicacid |
trans-p-Cumaric Acid |
4-Hydroxycinamic acid |
.BETA.-(4-HYDROXYPHENYL)ACRYLIC ACID |
2-Propenoic acid, 3-(4-hydroxyphenyl)-, (Z)- |
CHEBI:36090 |
hydroxycinnamate |
Para coumarate |
p-coumaric-acid |
Para-Coumarate |
p-Cumarate |
naringeninic-acid |
p-Hydroxycinnamate |
4qem |
Coumaric acid, p- |
4'-Hydroxycinnamate |
4-Hydroxy cinnamate |
p-Coumaric acid,trans |
p-Coumaric acid 98% |
4f8j |
p-Coumaric acid, trans |
4-Hydroxyphenylpropenoate |
(2E)-3-(4-Hydroxyphenyl)-2-propenoic acid |
trans-3-(4'-hydroxyphenyl)-2-propenoic acid |
bmse000150 |
bmse000591 |
bmse010208 |
trans-4-HydroxycinnamicAcid |
b-[4-Hydroxyphenyl]acrylate |
SCHEMBL39106 |
p-hydroxycinnamic acid (M4) |
MLS001066419 |
p-Hydroxycinnamic acid, trans |
P-COUMARIC ACID [MI] |
beta-[4-Hydroxyphenyl]acrylate |
BDBM4374 |
GTPL5787 |
SODIUM2,4-PENTANEDIONATE |
b-[4-Hydroxyphenyl]acrylic acid |
trans-p-HydroxyzimtsA currencyure |
DTXSID30901076 |
P-COUMARIC ACID [WHO-DD] |
HMS1409E10 |
3-(4-Hydroxyphenyl)-2-propenoate |
HYDROXYCINNAMIC ACID [INCI] |
BCP22803 |
HY-N2391 |
NSC59260 |
STR06515 |
4-HYDROXYPHENYLPROPENOIC ACID |
Cinnamic acid, 4-hydroxy-, trans- |
AC7957 |
BBL012226 |
CK2547 |
s4759 |
s9564 |
STL163567 |
AKOS000120685 |
p-Coumaric acid;p-Hydroxycinnamic acid |
BCP9001042 |
CCG-266309 |
CS-W020394 |
DB04066 |
p-Coumaric acid, >=98.0% (HPLC) |
(E)-3-(4-hydroxyphenyl)prop-2-enoate |
NCGC00246974-01 |
1ST40051 |
50940-26-6 |
AC-10318 |
AC-34130 |
AC-34133 |
AS-12000 |
BP-13278 |
SMR000112201 |
(E)-3-(4-hydroxyphenyl)prop-2-enoicacid |
trans-p-Coumaric acid, analytical standard |
AM20050138 |
NS00068187 |
EN300-17292 |
A19490 |
C00811 |
Q99374 |
(2E)-3-(4-Hydroxyphenyl)-2-propenoic acid # |
A828008 |
AE-562/40414679 |
trans-p-Coumaric acid 1000 microg/mL in Acetone |
Q-100560 |
W-104438 |
Z56911963 |
0C1BFF2D-2CF7-4FC1-9F76-3268C2C7F783 |
F2191-0188 |
p-Coumaric acid, primary pharmaceutical reference standard |
(E)-3-(4-hydroxyphenyl)prop-2-enoate;Trans-4-Hydroxycinnamic Acid |
InChI=1/C9H8O3/c10-8-4-1-7(2-5-8)3-6-9(11)12/h1-6,10H,(H,11,12)/b6-3 |